Wednesday, July 27, 2016

UPDATE 1-Teva purchase of Allergan generics business gets OK with conditions

WASHINGTON, July 27 (Reuters) - Teva Pharmaceutical

Industries Ltd won U.S. antitrust approval to purchase

Allergan Plc's generics business, after agreeing to

divest more than 75 generic drugs to...

Read more

No comments:

Post a Comment